Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:393-398
Published online before print December 29, 2005, doi: 10.1161/01.STR.0000198878.66000.4e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/2/393    most recent
01.STR.0000198878.66000.4ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuroda, S.
Right arrow Articles by Iwasaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuroda, S.
Right arrow Articles by Iwasaki, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN

(Stroke. 2006;37:393.)
© 2006 American Heart Association, Inc.


Original Contributions

Cerebral Oxygen Metabolism and Neuronal Integrity in Patients With Impaired Vasoreactivity Attributable to Occlusive Carotid Artery Disease

Satoshi Kuroda, MD, PhD; Tohru Shiga, MD, PhD; Kiyohiro Houkin, MD, PhD; Tatsuya Ishikawa, MD, PhD; Chietsugu Katoh, MD, PhD; Nagara Tamaki, MD, PhD Yoshinobu Iwasaki, MD, PhD

From the Departments of Neurosurgery (S.K., T.I., Y.I.) and Nuclear Medicine (T.S., C.K., N.T.), Hokkaido University Graduate School of Medicine, Japan; and Department of Neurosurgery (K.H.), Sapporo Medical University, Japan.

Correspondence to Satoshi Kuroda, MD, PhD, Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan. E-mail skuroda{at}med.hokudai.ac.jp

Background and Purpose— It is still unclear that impaired cerebrovascular reactivity (CVR) to acetazolamide is comparable to elevated oxygen extraction fraction (OEF) on positron emission tomography (PET) in patients with occlusive carotid diseases. Therefore, in this study, the authors aimed to clarify whether OEF is elevated in all patients with reduced cerebral blood flow (CBF) and CVR (type 3) on single photon emission computed tomography (SPECT), and, if not, to specify the underlying pathophysiology of type 3 but normal OEF.

Methods— This study included 46 patients who had decreased CBF and CVR on N-isopropyl-p-123I-iodoamphetamine SPECT in the ipsilateral middle cerebral artery area attributable to occlusive carotid diseases. Hemodynamic and metabolism parameters were determined in all patients by 15O-gas PET, and neuronal integrity was evaluated in 19 patients using 11C-flumazenil (FMZ) PET.

Results— OEF was significantly elevated in 20 (43.5%) of 46 type 3 patients. Another 26 type 3 patients had normal OEF. Regression analysis showed that OEF significantly correlated with cerebral metabolic rate for oxygen and 11C-FMZ binding potential but not with other parameters. Subcortical infarction had no significant effect on OEF values.

Conclusions— The results strongly suggest that type 3 patients with reduced CBF and CVR may be divided into 2 pathophysiologically different subgroups: misery perfusion attributable to hemodynamic compromise and matched hypometabolism attributable to incomplete infarction. Type 3 but normal OEF may represent a transition stage from misery perfusion to matched hypometabolism.


Key Words: acetazolamide • cerebral ischemia • flumazenil • metabolism • oxygen




This article has been cited by other articles:


Home page
StrokeHome page
D. Ishigaki, K. Ogasawara, Y. Yoshioka, K. Chida, M. Sasaki, S. Fujiwara, K. Aso, M. Kobayashi, K. Yoshida, K. Terasaki, et al.
Brain Temperature Measured Using Proton MR Spectroscopy Detects Cerebral Hemodynamic Impairment in Patients With Unilateral Chronic Major Cerebral Artery Steno-Occlusive Disease: Comparison With Positron Emission Tomography
Stroke, September 1, 2009; 40(9): 3012 - 3016.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A.S. Vagal, J.L. Leach, M. Fernandez-Ulloa, and M. Zuccarello
The Acetazolamide Challenge: Techniques and Applications in the Evaluation of Chronic Cerebral Ischemia
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 876 - 884.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Hokari, S. Kuroda, T. Shiga, N. Nakayama, N. Tamaki, and Y. Iwasaki
Combination of a Mean Transit Time Measurement with an Acetazolamide Test Increases Predictive Power to Identify Elevated Oxygen Extraction Fraction in Occlusive Carotid Artery Diseases
J. Nucl. Med., December 1, 2008; 49(12): 1922 - 1927.
[Abstract] [Full Text] [PDF]